Tokyo Tape
Sign in
5% STAKE4594.TTSECAYMAN ISLANDS

Evo Fund lowers stake in BrightPath Biotherapeutics to 20.13%

Stake history

18%20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN21.62%Aug 26Aug 26: 21.62% · S100U9TY20.93%Sep 27Sep 27: 20.93% · S100UFJ420.13%Oct 25Oct 25: 20.13% · S100UKS0
18%20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN21.62%Aug 26Aug 26: 21.62% · S100U9TY20.93%Sep 27Sep 27: 20.93% · S100UFJ420.13%Oct 25Oct 25: 20.13% · S100UKS0

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-25 10:21 JST concerning BrightPath Biotherapeutics Co., Ltd. Reported holding ratio: 20.13%, previous report: 20.93%.

Stock price4594 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100UKS0 ↗ · PDL1.0 · Not investment advice